Next Article in Journal
Compatibility Studies of Sildenafil-HPBCD Inclusion Complex with Pharmaceutical Excipients
Previous Article in Journal
Neurotoxicological Evaluation of Intrathecal Citrate Excipients: Calcium Homeostasis Disruption and Safety Implications in CNS Drug Delivery
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196

by
Jorge Iván Castro
1,
Daniela G. Araujo-Rodríguez
2,
Carlos Humberto Valencia-Llano
3,
Diego López Tenorio
3,
Marcela Saavedra
4,
Paula A. Zapata
4 and
Carlos David Grande-Tovar
2,*
1
Laboratorio SIMERQO, Departamento de Química, Universidad del Valle, Calle 13 No. 100-00, Cali 76001, Colombia
2
Grupo de Investigación de Fotoquímica y Fotobiología, Universidad del Atlántico, Carrera 30 Número 8-49, Puerto Colombia 081008, Colombia
3
Grupo Biomateriales Dentales, Escuela de Odontología, Universidad del Valle, Calle 4B # 36-00, Cali 76001, Colombia
4
Grupo de Polímeros, Facultad de Química y Biología, Universidad de Santiago de Chile, Santiago 9170020, Chile
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(9), 1113; https://doi.org/10.3390/pharmaceutics17091113
Submission received: 10 July 2025 / Accepted: 19 August 2025 / Published: 27 August 2025
(This article belongs to the Section Drug Targeting and Design)

Error in Figure

In the original publication [1], there was a mistake in Figure 6 as published. We mistakenly duplicated a macroscopic photo of a biomodel implanted with different scaffolds, previously published in [2]. This error occurred because we usually use the same animal biomodels to evaluate different materials simultaneously, employing a subdermal implantation model that allows the creation of up to 10 pockets per animal, each containing a different material. In some cases, two or three different systems were implanted in the same biomodel, as per the experimental design. This experimental strategy optimizes animal use, minimizes inter-individual variability, and facilitates direct comparisons between the materials studied under controlled conditions, thereby complying with the principles of the 3Rs (Replacement, Reduction, and Refinement).
The figure in question corresponds to a macroscopic image of the dorsal area of implantation in the biomodel. This type of image is typically included as a preliminary visual representation of the tissue response. It serves as complementary evidence to the histological findings, which constitute the primary support for the article’s conclusions. The figure, intended solely as a preliminary visual context, does not affect the scientific validity, results, or conclusions of the article. The corrected Figure 6 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

References

  1. Castro, J.I.; Araujo-Rodríguez, D.G.; Valencia-Llano, C.H.; López Tenorio, D.; Saavedra, M.; Zapata, P.A.; Grande-Tovar, C.D. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. [Google Scholar] [CrossRef] [PubMed]
  2. Grande-Tovar, C.D.; Castro, J.I.; Valencia Llano, C.H.; López Tenorio, D.; Saavedra, M.; Zapata, P.A.; Chaur, M.N. Polycaprolactone (PCL)-Polylactic Acid (PLA)-Glycerol (Gly) Composites Incorporated with Zinc Oxide Nanoparticles (ZnO-NPs) and Tea Tree Essential Oil (TTEO) for Tissue Engineering Applications. Pharmaceutics 2023, 15, 43. [Google Scholar] [CrossRef] [PubMed]
Figure 6. Subdermal dorsal implantation zone. (A) Dorsal area with abundant hair. (B) Trichotomy of dorsal area. (C) Subdermal implantation area. Black ovals: implantation zone. White circles: blocks implanted. F1–F4: formulations 1, 2, 3, and 4. IZ: Implantation zone.
Figure 6. Subdermal dorsal implantation zone. (A) Dorsal area with abundant hair. (B) Trichotomy of dorsal area. (C) Subdermal implantation area. Black ovals: implantation zone. White circles: blocks implanted. F1–F4: formulations 1, 2, 3, and 4. IZ: Implantation zone.
Pharmaceutics 17 01113 g006
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Castro, J.I.; Araujo-Rodríguez, D.G.; Valencia-Llano, C.H.; López Tenorio, D.; Saavedra, M.; Zapata, P.A.; Grande-Tovar, C.D. Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics 2025, 17, 1113. https://doi.org/10.3390/pharmaceutics17091113

AMA Style

Castro JI, Araujo-Rodríguez DG, Valencia-Llano CH, López Tenorio D, Saavedra M, Zapata PA, Grande-Tovar CD. Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics. 2025; 17(9):1113. https://doi.org/10.3390/pharmaceutics17091113

Chicago/Turabian Style

Castro, Jorge Iván, Daniela G. Araujo-Rodríguez, Carlos Humberto Valencia-Llano, Diego López Tenorio, Marcela Saavedra, Paula A. Zapata, and Carlos David Grande-Tovar. 2025. "Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196" Pharmaceutics 17, no. 9: 1113. https://doi.org/10.3390/pharmaceutics17091113

APA Style

Castro, J. I., Araujo-Rodríguez, D. G., Valencia-Llano, C. H., López Tenorio, D., Saavedra, M., Zapata, P. A., & Grande-Tovar, C. D. (2025). Correction: Castro et al. Biocompatibility Assessment of Polycaprolactone/Polylactic Acid/Zinc Oxide Nanoparticle Composites Under In Vivo Conditions for Biomedical Applications. Pharmaceutics 2023, 15, 2196. Pharmaceutics, 17(9), 1113. https://doi.org/10.3390/pharmaceutics17091113

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop